Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients

Published: 14 August 2019
Author(s): Geoffroy Venton, Mihai Turcanu, Julien Colle, Franck Thuny, Safia Chebrek, Laure Farnault, Cédric Mercier, Vadim Ivanov, Raphaëlle Fanciullino, Pierre Suchon, Pierre-André Jarrot, Karim Aissi, Pauline Roche, Jennifer Cautela, Robin Arcani, Regis Costello
Issue: August 2019
Section: Original Article

Chronic myeloproliferative neoplasms (MPN) are recognized as a cause of pulmonary hypertension (pH). We ought to describe the prevalence and characteristics of PH in a cohort of MPN who were screened using transthoracic echocardiography (TTE).